会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Topical use of ingenol-3-angelate or a salt thereof to treat skin cancer
    • 局部使用美沙芬-3-安息香酸盐或其盐治疗皮肤癌
    • US09314458B2
    • 2016-04-19
    • US13034172
    • 2011-02-24
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61P35/00A61P17/04A61P31/22A61K31/455A61K31/22A61K36/47
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/481Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogs or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analog or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防炎性病症或改善由哺乳动物(包括人类和灵长类,非哺乳动物和禽类)物种中的炎性病症引起或促进的症状的化学试剂。 更具体地说,本发明提供了从大戟科植物或植物或园艺亲属的成员获得的大环二萜类家族化学试剂或衍生物或化学类似物或用于治疗或预防的药剂的化学合成形式 的炎性病症或改善由哺乳动物,动物或禽类物种中的炎性病症引起或促进的症状。 本发明进一步考虑了一种用于预防或治疗哺乳动物,动物或禽类受试者的炎症性疾病的方法,包括慢性或短暂性炎性病症或通过局部或全身给予大环二萜来改善炎症状态的症状,所述大环二萜可从 大戟科(Euphorbiaceae)家族的成员或植物或园艺亲属或衍生物,化学类似物或化学合成形式的药剂。 本发明的化学试剂可以是纯化的化合物,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式, 子部分或植物的制备或提取物。
    • 2. 发明授权
    • Therapeutic agents—I
    • 治疗剂 - I
    • US07449492B2
    • 2008-11-11
    • US10315288
    • 2002-12-09
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61K31/21
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/481Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of infection by pathogenic or potentially pathogenic entities, or entities capable of opportunistic infection in mammals, including humans and primates, non-mammalian animals and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of infection by pathogenic entities in mammalian, animal and avian subjects. The present invention further contemplates a method for the prophylaxis and/or treatment in mammalian, animal or avian subjects of infection or potential infection by pathogenic entities by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family of plants or their botanical or horticultural derivatives or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or in the form of a chemical fraction, sub-fraction, preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防致病或潜在致病实体或能够在包括人和灵长类动物,非哺乳动物和禽类物种在内的哺乳动物中机会感染的实体的感染的化学试剂。 更具体地说,本发明提供了一种可从植物或植物或园艺亲属的大戟科家族成员获得的大环二萜类化合物或用于治疗或预防的药剂的衍生物或化学类似物或化学合成形式 在哺乳动物,动物和禽类受试者中感染病原体。 本发明进一步考虑了一种通过局部或全身施用可从植物大戟科植物的成员获得的大环二萜在哺乳动物,动物或禽类受试者中预防和/或治疗感染或潜在感染的方法,或 其植物或园艺衍生物或衍生物,化学类似物或化学合成形式的药剂。 本发明的化学试剂可以是纯化合物的形式,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式 - 植物的分离,制备或提取。
    • 4. 发明申请
    • MACROCYCLIC DITERPENES FOR TREATING CONDITIONS ASSOCIATED WITH PROTEIN KINASE C
    • 用于处理与蛋白激酶C相关的条件的大分子化合物
    • US20110213002A1
    • 2011-09-01
    • US13034172
    • 2011-02-24
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61K31/465A61K31/22A61P11/06A61P9/00A61P7/00A61P25/28A61P25/24A61P3/10A61P25/00A61P19/00A61P31/12A61P17/06A61K31/122
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/481Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防炎性病症或改善由哺乳动物(包括人类和灵长类,非哺乳动物和禽类)物种中的炎性病症引起或促进的症状的化学试剂。 更具体地说,本发明提供从大戟科植物或植物或园艺亲属的成员获得的大环二萜类家族化学试剂或用于治疗或预防的药剂的衍生物或化学类似物或化学合成形式 的炎性病症或改善由哺乳动物,动物或禽类物种中的炎性病症引起或促进的症状。 本发明进一步考虑了一种用于预防或治疗哺乳动物,动物或禽类受试者的炎症性疾病的方法,包括慢性或短暂性炎性病症或通过局部或全身给予大环二萜来改善炎症状态的症状,所述大环二萜可从 大戟科的成员或植物或园艺亲属或衍生物,化学类似物或化学合成形式的药剂。 本发明的化学试剂可以是纯化的化合物,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式, 子部分或植物的制备或提取物。
    • 5. 发明申请
    • MACROCYCLIC DITERPENES FOR TREATING CONDITIONS ASSOCIATED WITH PROTEIN KINASE C
    • 用于处理与蛋白激酶C相关的条件的大分子化合物
    • US20100048698A1
    • 2010-02-25
    • US12543087
    • 2009-08-18
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • James Harrison AylwardPeter Gordon ParsonsAndreas SuhrbierKathleen Anne Turner
    • A61K31/215A61P29/00
    • A61K31/455A61K31/22A61K36/47C07C69/533Y02A50/401Y02A50/402Y02A50/409Y02A50/414Y02A50/415Y02A50/463Y02A50/465Y02A50/469Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/483Y02A50/491Y02A90/26
    • The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Fuphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.
    • 本发明一般涉及用于治疗和预防炎性病症或改善由哺乳动物(包括人类和灵长类,非哺乳动物和禽类)物种中的炎性病症引起或促进的症状的化学试剂。 更具体地说,本发明提供从大戟科植物或植物或园艺亲属的成员获得的大环二萜类家族化学试剂或用于治疗或预防的药剂的衍生物或化学类似物或化学合成形式 的炎性病症或改善由哺乳动物,动物或禽类物种中的炎性病症引起或促进的症状。 本发明进一步考虑了一种用于预防或治疗哺乳动物,动物或禽类受试者的炎症性疾病的方法,包括慢性或短暂性炎性病症或通过局部或全身给予大环二萜来改善炎症状态的症状,所述大环二萜可从 大戟科(Fuphorbiaceae)家族的成员或其植物或园艺亲属,或代理人的衍生,化学类似物或化学合成形式。 本发明的化学试剂可以是纯化的化合物,化合物的混合物,能够化学转化成治疗活性剂或以化学级分形式的一种或多种化合物的前体形式, 子部分或植物的制备或提取物。
    • 8. 发明授权
    • Anti-tumor agents comprising pyridyl-substituted metal-diphosphine complex
    • 抗肿瘤剂包括吡啶基取代的金属 - 二膦配合物
    • US06218378B1
    • 2001-04-17
    • US08860518
    • 1997-08-22
    • Susan Jane Berners-PriceRichard John BowenPeter Gordon Parsons
    • Susan Jane Berners-PriceRichard John BowenPeter Gordon Parsons
    • A01N5502
    • A61K31/675C07F9/5059C07F9/5068C07F9/58Y10T428/12396Y10T428/12444
    • A method of treatment or inhibition of tumors including the steps of: (i) exchanging one or more of the eight phenyl substituents in the compound [M(dppe)2]+ where M is selected from Au(I), Ag(I) and Cu(I) by 2, 3, or 4 pyridyl substituents to provide a compound having anti-tumor activity and an octanol/water partition coefficient between 0.01 and 25.5; and (ii) administering said compound to a subject requiring treatment which compound has selective toxicity to cancer cells including cisplatin resistant human carcinoma cell lines. The invention also includes within its scope compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are the same or different and may be selected from phenyl, 4-pyridyl, 3-pyridyl, 2-pyridyl wherein each of the 4-pyridyl, 3-pyridyl and 2-pyridyl may optionally be substituted; A is selected from —(CH2)— wherein n is 2 or 3 or cis —CH═CH— or (a) where R9 represents carboxylate and in such case R1, R2, R3, R4, R5, R6, R7 and R8, may be all phenyl; M is Au(I), Ag(I) or Cu(I); X is monovalent anion such as nitrate or bromide, chloride, iodine or any other non-toxic anion; with the following provisos: (i) R1 through R8 cannot be all phenyl; (ii) when R1 through R8 is 2-pyridyl, and A is —(CH2)2—, M cannot be Au(I); or (iii) when R1 through R8 is the same and is 4-pyridyl, X is Cl and A is —(CH2)2—, M cannot be Au(I).
    • 一种治疗或抑制肿瘤的方法,包括以下步骤:(i)在化合物[M(dppe)2] +中交换一个或多个八个苯基取代基,其中M选自Au(I),Ag(I) 和Cu(I)2,3或4个吡啶基取代基,以提供具有抗肿瘤活性和辛醇/水分配系数在0.01至25.5之间的化合物; 和(ii)向需要治疗的受试者施用所述化合物,所述化合物对包括顺铂耐药性人癌细胞系的癌细胞具有选择性毒性。 本发明还包括其范围内的式(I)化合物,其中R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8相同或不同,并且可以选自苯基,4-吡啶基,3-吡啶基, - 吡啶基,其中每个4-吡啶基,3-吡啶基和2-吡啶基可任选被取代; A选自 - (CH 2) - ,其中n为2或3或顺式-CH = CH-或(a)其中R9表示羧酸盐,在这种情况下,R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8, 可能全部为苯基; M是Au(I),Ag(I)或Cu(I); X是一价阴离子,如硝酸盐或溴化物,氯化物,碘或任何其他无毒阴离子; 具有以下条件:(i)R 1至R 8不能全部为苯基; (ii)当R 1至R 8为2-吡啶基且A为 - (CH 2)2 - 时,M不能为Au(I); 或(iii)当R 1至R 8相同且为4-吡啶基时,X为Cl且A为 - (CH 2)2 - ,M不能为Au(I)。